期刊文献+

磁共振波谱导航在颅内病变穿刺活检中的应用 被引量:1

Preliminary Application of Magnetic Resonance Spectroscopy Guided Navigation in Needle Biopsy of Intracranial Lesions
下载PDF
导出
摘要 目的:探讨氢质子磁共振波谱(proton magnetic resonance spectroscopy,1H-MRS)代谢影像导航在脑内病变穿刺活检中的应用。方法:选择颅内部病变患者28例,采用1H-MRS分析病灶组织的生化及代谢情况,采用自主设计软件Biopsy NAV将MRS代谢影像与3D结构影像融合,设计合理的穿刺轨迹和靶点,取得穿刺病理标本。28例中27例患者穿刺活检后再行开颅手术切除病灶并进行病理学检查。结果:28例颅内部病变患者病理诊断成功率100%(28/28)。穿刺病理与术后病理学检测符合率100%(27/27),所有患者术中及术后均未出现明显并发症。结论:1H-MRS代谢影像导航能提供病变的代谢信息并帮助确定最佳活检取材点,穿刺活检诊断成功率较常规结构影像导航高。 Objective:To explore the application of 1H-MRS guided navigation in needle biopsy of intracranial lesions . Methods :1H-MRS was used in 28 patients with intracranial lesions to analyze the biochemical and metabolic situation of the le-sions and find out the optimal puncture path and biopsy target to get pathological specimens ,by combining the 1H-MRS meta-bolic image and frame image together with independently designed software Biopsy NAV .Among them ,27 patients accept cra-niotomy and pathology inspection after needle biopsy .Results:In all 28 cases with introcranial lesions ,the pathologic diagnosis success rate is 100% (28/28) .The pathological diagnosis made from needle biopsy was 100% (27/27) in accordance with post operative pathology inspection .None of the patients suffered from significant complications during and after the operation . Conclusions :1H-MRS is useful in analyzing metabolism of the lesions and selecting the best biopsy target ,so that the needle bi-opsy success rate is higher than common frame image navigation .
出处 《中国临床医学》 2014年第3期269-272,共4页 Chinese Journal of Clinical Medicine
基金 上海市金山区科委基金资助项目(编号:2013-3-14)
关键词 氢质子磁共振波谱 神经导航 活组织检查 颅内病变 Proton magnetic resonance spectroscopy Neuronavigation Biopsy Intracranial lesions
  • 相关文献

参考文献8

  • 1林江,周康荣,陈祖望.质子磁共振波谱用于鉴别颅内病变良恶性和肿瘤恶性程度初探[J].临床放射学杂志,2005,24(5):385-388. 被引量:3
  • 2Owen C, Linskey M. Frame-based stereotaxy in a frameless era: current capabilities, relative role, and the positive and negative predictive values of blood through the needle[J]. J Neurooncol, 2009,93(1) : 139-149.
  • 3Lundsford LD. Diagnosis and treatment of brain lesions using the Leksell stereotactic system. In: Lundsford LD (ed) Modern stereotactic neurosurgery [J]. Martinus-Nijhoff , 1989, 145-168.
  • 4Edward EG, Sarah IN , Daniel BV, et al. Serial protonMR spectroscopic imaging of recurrent malignant gliomas after gamma knife radiosurgery[J]. American Journal of Neuroradiology, 2001,22(4):613-621.
  • 5Smith JS, Quinones-Hinojosa A, Barbaro NM, et al. Framebased stereotactic biopsy remains an important diagnostic tool with distinct advantages over frameless stereotactic biopsy [J]. J Neurooncol , 2005,73(2) :173-179.
  • 6Sawin PD, Hitchon PW, Follett KA. Computed imaging-assisted stereotactic brain biopsy: a risk analysis of 225 consecutive cases[J]. Surg Neurol, 1998,49(6): 640-649.
  • 7Wu JS, Zhou LF, Tang WJ, et al. Clinical evaluation and follow-up outcome of diffusion tension imaging-based functional neuronavigation , a prospective, controlled study in patients with gliomas involving pyramidal tracts DJ. Neurosurgery, 2007,61(5) : 935-948; discussion 948-939.
  • 8Walter A, Haiying Liu, Charles L. Magnetic resonance spectroscopy-guided biopsy of intracranial tumorsj]]. Techniques in Neurosurgery,2002, 7 :291-298.

二级参考文献13

  • 1Burtscher IM, Holtas S. Proton MR spectroscopy in clinical routine. J Magn Reson Imaging, 2001, 13:560.
  • 2Vigneron D, Bollen A, McDermont M,et al. Three-dimensional magnetic spectroscopic imaging of histologically confirmed brain tumors. Magnetic Resonance Imaging, 2001, 19:89.
  • 3Ott D, Hennig J, and Ernst T. Human brain tumors: assessment with in vivo proton MR spectroscopy. Radiology, 1993, 186:745.
  • 4Rand SD, Prost R, Haughton V,et al. Accuracy of single-voxel proton MR spectroscopy in distinguishing neoplastic from nonneoplastic brain lesions. Am J Neuroradiol, 1997, 18:1695.
  • 5Shimizu H, Kumabe T, Tominaga T,et al. Noninvasive evaluation of malignancy of brain tumors with proton MR spectroscopy. Am J Neuroradiol, 1996, 17:737.
  • 6Krouwer HG, Kim TA, Rand SD,et al. Single-voxel proton MR spectroscopy of nonneoplastic brain lesions suggestive of a neoplasm. Am J Neuroradiol, 1998, 19:1695.
  • 7Speck O, Thiel T, and Hennig J. Grading and therapy monitoring of astrocytomas with 1 H-spectroscopy:preliminary study. Anticancer Res, 1996, 16:1581.
  • 8Chang KH, Song IC, Han MH,et al. In vivo Single-voxel proton MR spectroscopy in intracranial cystic masses. Am J Neuroradiol, 1998, 19:401.
  • 9Gotsis ED, Fountas K, Kapsalaki E,et al. In vivo proton MR spectroscopy: the diagnostic possibilities of lipid resonances in brain tumors. Anticancer Res, 1996, 16:1565.
  • 10Lin A, Bluml S, and Mamelak AN. Efficacy of proton magnetic resonance spectroscopy in clinical decision making for patients with suspected malignant brain tumors. J Neurooncol 1999, 45:69.

共引文献2

同被引文献17

  • 1Apuzzo ML, Chandrasoma PT, Cohen D, et al, Computed imaging stereotaxy: experience and perspective related to 500 procedures applied to brain masses[J]. Neurosurgery, 1987,20(6):930-937.
  • 2Bertholdo D, Wateharakorn A, Castillo M. Brain proton magnet- ic resonance spectroscopy: introduetion and overview[J]. Neuro- imaging Clin N Am, 2013,23(3):359-380.
  • 3Soares DP, Law M. Magnetic resonanee spectroscopy of the brain: review of metabolites and clinical applications[J]. Clin Radiol, 2009,64( 1 ): 12-21.
  • 4Bulik M, Jancalek R, Vanicek J, et al. Potential of MR spectros- copy for assessment of glioma grading[J]. Clin Neurol Neuro- surg, 2013,115(2):146-153.
  • 5Lowry OH, Berger SJ, Carter JG, et al. Diversity of metabolic patterns in human brain tumors: enzymes of energy metabolism and related metabolites and cofactors[J]. J Neurochem, 1983,41 (4):994-1010.
  • 6Kleihues P. Pathology and genetics of tumours of the nervous system[M]//Kleihues P CWK, editors. World Health Organiza- tion classification of tumors. Lyon: IARC Press, 2000.
  • 7Chernov M, Muragaki Y, Taira T, et al. 1 H-MRS-guided stereotac- tic brain biopsy[J]. Stereotact Funct Neurosurg, 2012,90(1):63-65.
  • 8Frati A, Pichierri A, Bastianello S, et al. Frameless stereotactic cerebral biopsy: our experience in 296 cases[J]. Stereotact Funct Neurosurg, 2011,89(4):234-245.
  • 9Bradac O, Vrana J, Jiru Fit et al. Recognition of anaplastic foci within low-grade gliomas using MR_ spectroscopy[J]. Br J Neuro- surg, 2014,28(5):631-636.
  • 10Nafe R, Herminghaus S, Raab P, et al. Preoperative proton-MR spectroscopy of gliomas-cmTelation with quantitative nuclear morphology in surgical specimen[J]. J Neurooncol, 2003,63(3): 233-245.

引证文献1

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部